Home > PJ (current issue) > Leading articles | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7334 p100
29 January 2005

This article
Reprint   Photocopy

PDF 45K, Acrobat Reader

Leading Articles

Unintended consequences more
Focus on Iraq more


Unintended consequences

Medication reviews were given a bad press last week. A paper in the BMJ suggested that, if anything, pharmacist interventions caused more problems than they solved and patients were more likely to find themselves in hospital after a review than if they had been left in peace and quiet.

However, before pharmacists start tearing their hair out and wondering why on earth medicines use reviews have been given such an important role to play in the new community pharmacy contracts, they should read the News feature on p106. This puts the findings in context. The researchers acknowledge, for example, that, in the particular patient group studied (people who had recently been discharged from hospital), pharmacist intervention might have improved patients’ adherence to their medicines and, as a result, the patients, who were old, tended to suffer more side effects. That, in turn, could have led to their readmission to hospital. This may be a case of unintended consequences rather than any real shortcomings with the overall concept of medication reviews.

There is a huge body of research that indicates that patients tend not to take their medicines appropriately for maximum clinical benefit. In younger patients who are chronically ill and older patients who have not been admitted to hospital, it is not yet fully known what the impact of pharmacist-led medicines use review might be on targeted groups of people. So the BMJ paper should be seen as an invitation to carry out more research to determine where exactly the benefits of MUR lie and what its limitations are. This is likely to strengthen the case for MURs which, at the moment, may seem little more than common sense.

Back to Top

Focus on Iraq

Readers might wonder why The Journal has chosen to focus on Iraq, although the first national election planned for this weekend provides a timely hook for an Article on the current pharmaceutical chaos in that country (p115). After all, it does not have anything to do with pharmacy practice in Britain and many people may be beginning to feel compassion fatigue after being bombarded with images from the fringes of the Indian Ocean over the past few weeks.

However, we decided that the article, based on e-mails from an academic pharmacist at the University of Tikrit, paints such a bleak but moving picture of pharmacy in a country where the UK Government, for better or worse, has decided to play a significant role that pharmacists here might like to be aware of the privations suffered on a daily basis. The tragedy is that people are powerless to do anything much to help and there does not seem to be any glimmer of hope.

Back to Top


©The Pharmaceutical Journal